» Articles » PMID: 26273604

The Potential Role of Iron and Copper in Pediatric Obesity and Nonalcoholic Fatty Liver Disease

Overview
Journal Biomed Res Int
Publisher Wiley
Date 2015 Aug 15
PMID 26273604
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Obesity is a rapidly growing health problem and is paralleled by a multitude of comorbidities, including nonalcoholic fatty liver disease (NAFLD). NAFLD has become the most common chronic liver disease in both adults and children. The current understanding of NAFLD is still fragmentary. While simple steatosis is characterized by the interplay between excessive free fatty acid accumulation and hepatic insulin resistance, the progression to NASH has been related to oxidative stress and a proinflammatory state with dysbalanced adipokine, cytokine levels, and endotoxin-mediated immune response. In addition, oxidative stress has been suggested to play a central role for the sequelae leading to NASH. Trace elements are critical in regulatory, immunologic, and antioxidant functions resulting in protection against inflammation and peroxidation and consequently against the known comorbidities of obesity. Disruptions of the metal detoxification processes located in the liver are plausibly related to NAFLD development via oxidative stress. Perturbations of iron and copper (Cu) homeostasis have been shown to contribute to the pathogenesis of NAFLD. This review presents current data from pediatric studies. In addition, data from adult studies are summarized where clinical relevance may be extrapolated to pediatric obesity and NAFLD.

Citing Articles

Cuproptosis Cell Death Molecular Events and Pathways to Liver Disease.

Mao Y, Chen H, Zhu W, Ni S, Luo S, Tang S J Inflamm Res. 2025; 18:883-894.

PMID: 39867947 PMC: 11760270. DOI: 10.2147/JIR.S498340.


Overweight, Obesity, Hypertriglyceridemia, and Insulin Resistance Are Positively Associated with High Serum Copper Levels in Mexican Adults.

Ramirez-Cruz A, Rios-Lugo M, Soto-Sanchez J, Juarez-Perez C, Cabello-Lopez A, Jimenez-Ramirez C Metabolites. 2024; 14(5).

PMID: 38786759 PMC: 11122773. DOI: 10.3390/metabo14050282.


Arbutin alleviates fatty liver by inhibiting ferroptosis via FTO/SLC7A11 pathway.

Jiang T, Xiao Y, Zhou J, Luo Z, Yu L, Liao Q Redox Biol. 2023; 68:102963.

PMID: 37984229 PMC: 10694775. DOI: 10.1016/j.redox.2023.102963.


Micronutrient Deficiency in Children and Adolescents with Obesity-A Narrative Review.

Calcaterra V, Verduci E, Milanta C, Agostinelli M, Todisco C, Bona F Children (Basel). 2023; 10(4).

PMID: 37189944 PMC: 10136772. DOI: 10.3390/children10040695.


Recent advances in the application of ionomics in metabolic diseases.

Zhang Y, Huang B, Jin J, Xiao Y, Ying H Front Nutr. 2023; 9:1111933.

PMID: 36726817 PMC: 9884710. DOI: 10.3389/fnut.2022.1111933.


References
1.
Aigner E, Strasser M, Haufe H, Sonnweber T, Hohla F, Stadlmayr A . A role for low hepatic copper concentrations in nonalcoholic Fatty liver disease. Am J Gastroenterol. 2010; 105(9):1978-85. DOI: 10.1038/ajg.2010.170. View

2.
Nobili V, Siotto M, Bedogni G, Rava L, Pietrobattista A, Panera N . Levels of serum ceruloplasmin associate with pediatric nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr. 2012; 56(4):370-5. DOI: 10.1097/MPG.0b013e31827aced4. View

3.
Pinhas-Hamiel O, Newfield R, Koren I, Agmon A, Lilos P, Phillip M . Greater prevalence of iron deficiency in overweight and obese children and adolescents. Int J Obes Relat Metab Disord. 2003; 27(3):416-8. DOI: 10.1038/sj.ijo.0802224. View

4.
Ferrari M, Mistura L, Patterson E, Sjostrom M, Diaz L, Stehle P . Evaluation of iron status in European adolescents through biochemical iron indicators: the HELENA Study. Eur J Clin Nutr. 2011; 65(3):340-9. PMC: 3049292. DOI: 10.1038/ejcn.2010.279. View

5.
Song M, Schuschke D, Zhou Z, Chen T, Pierce Jr W, Wang R . High fructose feeding induces copper deficiency in Sprague-Dawley rats: a novel mechanism for obesity related fatty liver. J Hepatol. 2011; 56(2):433-40. PMC: 3261305. DOI: 10.1016/j.jhep.2011.05.030. View